MedPath

Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis

Not Applicable
Recruiting
Conditions
Bronchiectasis
Interventions
Device: Acapella device
Other: Only routine chest physical therapy program
Registration Number
NCT05838144
Lead Sponsor
South Valley University
Brief Summary

1. Acapella group. Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program .

2. Only routine physical therapy program group ( control group). Will only take medications and routine chest physical therapy program.

Detailed Description

1. Acapella group.Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program.

2. Only routine physical therapy program group( control group). Will only take medications and routine chest physical therapy program Spirometer measures such as forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1) will be measured for every patient before and after the end of 7 days.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  1. bronchiectasis patients.
  2. Age range between 40 to 55 years old of both gender.
  3. Cooperative patients.
Exclusion Criteria
  1. Patients with severe cardiac disorders.
  2. Un controlled hypertensive patients.
  3. Un controlled diabetic patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AcapellaAcapella deviceWill use Acapella device 3 times per day for 15 minutes for 7 days beside medications and routine physical therapy program.
Only routine physical therapy programOnly routine chest physical therapy programOnly they will receive medications and routine physical therapy program.
AcapellaOnly routine chest physical therapy programWill use Acapella device 3 times per day for 15 minutes for 7 days beside medications and routine physical therapy program.
Primary Outcome Measures
NameTimeMethod
Spirometry measures7 days

FVC, FEV1

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shymaa yussuf abo zaid

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath